Join Treatment Action Group in an effort to help prioritize research for pregnant women with TB. Take action today, sign on to a community comment!
As the world’s leading infectious killer, tuberculosis (TB) affects pregnant women, and increases the likelihood of poor birth outcomes and death. Despite the urgent need for better TB prevention and treatment options, pregnant women remain woefully neglected by research initiatives. But we now have a chance to change the trajectory of research for pregnant women with TB, if you take action by August 14th.
On August 21-22, the newly-formed Taskforce on Research Specific to Pregnant and Lactating Women (PRGLAC) will meet for the first time. This taskforce will advise the Secretary of the U.S. Department of Health and Human Services (HHS) on ways the government can fill knowledge gaps for pregnant women.
Join Treatment Action Group (TAG) in an effort to help prioritize research for pregnant women with TB, by signing on to a community comment to PRGLAC on strategies the U.S. government can take to support research and researchers focused on meeting the needs of this vulnerable population. Strategies include the development of a TB medicine registry modeled after the Antiretroviral Pregnancy Registry (APR), and investigating ways to support the earlier inclusion of pregnant women in research.
Take action today:
- Click here to read and sign-on, individually and/or organizationally, to the letter and comment to PRGLAC.
- Click here to download an informational brief on how a TB medicines registry can benefit pregnant women with TB.
- Learn more about research issues for pregnant women with TB in a recently published community perspective in CID: Community perspective on the inclusion of pregnant women in TB drug trials.
Sign-on deadline: Monday, August 14, 2017 5:00pm EST